NCT05124184View on ClinicalTrials.gov

Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access

CompletedOBSERVATIONAL
Enrollment

356

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

July 22, 2024

Study Completion Date

July 22, 2024

Conditions
PAD - Peripheral Arterial DiseaseAAA - Abdominal Aortic AneurysmEnd-Stage Renal Disease
Interventions
DEVICE

GORE® PROPATEN® Vascular Graft

Patients that have had treatment with GORE® PROPATEN® Vascular Graft

DEVICE

GORE-TEX® Vascular Grafts

Patients that have had treatment with GORE-TEX® Vascular Grafts

Trial Locations (8)

Unknown

Centre Hospitalier Unversitaire d'Angers, Angers

CHRU de Besançon, Besançon

Les Hôpitaux Universitaires de Strasbourg, Strasbourg

Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, SOC Chirurgia Vascolare, Ancona

Unità di Chirurgia Vascolare Ospedale San Raffaele, Milan

Chirurgia Vascolare Azienda Ospedaliera Universitaria Integrata Verona, Verona

Hospital Clínico Universitario San Cecilio, Granada

08003

Hospital del Mar, Barcelona

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY